abstract:Daytrana (formerly known as MethylPatch) is a medicinal patch marketed and developed under contract by Noven Pharmaceuticals that was approved in April 2006. In the literature, Daytrana is most commonly referred to as Methylphenidate Transdermal System (MTS).